Flag of the European Union EU Clinical Trials Register Help

Clinical trials for NA

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44409   clinical trials with a EudraCT protocol, of which   7418   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    26,266 result(s) found for: NA. Displaying page 512 of 1,314.
    «« First « Previous 508  509  510  511  512  513  514  515  516  Next» Last»»
    EudraCT Number: 2008-008556-16 Sponsor Protocol Number: PRADA Start Date*: 2009-07-13
    Sponsor Name:Radboud University Nijmegen Medical Centre
    Full Title: Pharmacokinetic and safety study of RAltegravir and atazanavir in a once DAily dose regimen in HIV-1 in-fected patients (PRADA)
    Medical condition: HIV infected patients
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020161 HIV infection LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-014137-25 Sponsor Protocol Number: VARDENAFIL&DIABETES Start Date*: 2009-12-15
    Sponsor Name:Unita` Operativa di Endocrinologia e Malattie del Metabolismo
    Full Title: Monitoring of endothelial dysfunction during chronic administration of vardenafil in patients with type 2 diabetes mellitus: A longitudinal, randomised, placebo-controlled, double blind, phase II b...
    Medical condition: patients affected by type 2 Diabetes mellitus and affected by mild or severe ED
    Disease: Version SOC Term Classification Code Term Level
    12.0 10045248 Type II diabetes mellitus with other specified manifestations LLT
    Population Age: Adults Gender: Male
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-001292-11 Sponsor Protocol Number: NMSG 17/07 Start Date*: 2007-08-05
    Sponsor Name:Nordic Myeloma Study Group
    Full Title: Talidomid vs Velcade vid melfalanrefraktärt myelom
    Medical condition: Multiple myeloma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10028228 Multiple myeloma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-016596-30 Sponsor Protocol Number: FIBHGM-ECNC003-2010(FIBHGM-10-01) Start Date*: 2010-08-25
    Sponsor Name:Fundación para la Investigación Biomédica del Hospital Gregorio Marañón
    Full Title: CORTICOIDES PARA LA PREVENCIÓN DE LAS COMPLICACIONES DE LA VIA AÉREA POSTEXTUBACIÓN EN NIÑOS CRÍTICOS
    Medical condition: necesidad de intubación por cualquier patología
    Disease:
    Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-023962-39 Sponsor Protocol Number: 1014802/201 Start Date*: 2011-03-09
    Sponsor Name:Convergence Pharmaceuticals Ltd
    Full Title: A randomized, double blind, cross-over study to evaluate the safety and efficacy of CNV1014802 in subjects with neuropathic pain from lumbosacral radiculopathy
    Medical condition: Neuropathic pain from lumbosacral radiculopathy
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029205 - Nervous system disorders 10050219 Lumbar radiculopathy PT
    14.1 10029205 - Nervous system disorders 10054095 Neuropathic pain LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed) CZ (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2004-002782-20 Sponsor Protocol Number: H3E-MC-JMHH Start Date*: 2005-04-15
    Sponsor Name:Eli Lilly and Company Limited
    Full Title: A Phase 1 and 2 Clinical Trial of ALIMTA (Pemetrexed) in Combination with Carboplatin in Patients with Recurrent Ovarian or Primary Peritoneal Cancer
    Medical condition: platinum sensitive recurrent ovarian or primary peritoneal cancer
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DE (Completed) SE (Completed)
    Trial results: View results
    EudraCT Number: 2006-003075-12 Sponsor Protocol Number: 290478 Start Date*: Information not available in EudraCT
    Sponsor Name:Department Of Paediatric Cardiology
    Full Title: Effect of carvedilol on left ventricular systolic and diastolic function and the neurohormonal axis in patients with Duchenne muscular dystrophy and left ventricular dysfunction.
    Medical condition: Duchenne muscular dystrophy is an X-linked inherited disorder which primarily affects skeletal muscle through a mutation in dystrophin which maps to the long arm of the X chromosome (Xp21). Patient...
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-004634-24 Sponsor Protocol Number: IC51-314 Start Date*: 2008-09-18
    Sponsor Name:Intercell AG
    Full Title: IMMUNOGENICITY OF A COMMERCIAL BATCH OF THE JAPANESE ENCEPHALITIS VACCINE IC51 UP TO TWENTY-FOUR MONTHS POST FILLING, OPEN-LABEL, MULTICENTER, PHASE 3 STUDY
    Medical condition: Japanese Encephalitis (JE)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10014596 Encephalitis Japanese B PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) AT (Completed)
    Trial results: View results
    EudraCT Number: 2010-021270-11 Sponsor Protocol Number: CL2-05682-102 Start Date*: 2010-09-30
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: Impact of Daflon 500 mg on the progression of chronic venous disease and symptoms in patients operated on for varicose veins with conservation of the great saphenous vein. A multicentre, double bl...
    Medical condition: Patients suffering from chronic venous disease and for whom ASVAL (Ambulatory Selective Varicose veins Ablation Local anesthesia) surgery is indicated.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10066682 Chronic venous insufficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2008-005829-11 Sponsor Protocol Number: 080908 Start Date*: 2010-11-18
    Sponsor Name:FUNDACION CV INVESTIGACION HOSPITAL DR PESET
    Full Title: Mifepristona en la prevención del síndrome de hiperestimulación ovárica en tratamientos de reproducción asistida
    Medical condition: Mifepristona en la prevención del síndrome de hiperestimulación ovárica en tratamientos de reproducción asistida
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-001503-38 Sponsor Protocol Number: PolEver Start Date*: 2008-06-05
    Sponsor Name:AZIENDA OSPEDALIERA PROVINCIALE DI LECCO
    Full Title: effect of everolimus on adult polycystic nephropaty; a study pilot
    Medical condition: Autosomal Dominant Plycystic Kidney Disease
    Disease: Version SOC Term Classification Code Term Level
    9.1 10010607 Congenital renal cyst LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-006379-65 Sponsor Protocol Number: 02A801 Start Date*: 2008-10-27
    Sponsor Name:ISTITUTO AUXOLOGICO ITALIANO
    Full Title: Evaluation of the benefit-risk profile of retinoic acid in the treatment of Cushing`s disease
    Medical condition: sperimentation only in patients
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-012385-31 Sponsor Protocol Number: V87_17 Start Date*: 2009-09-01
    Sponsor Name:Novartis Vaccines and Diagnostics S.r.l.
    Full Title: A Phase II, Randomized, Controlled, Double-blind, Multi-center, Study to Evaluate Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 (Surface Antigen Adj...
    Medical condition: Avian influenza
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: View results
    EudraCT Number: 2009-013547-11 Sponsor Protocol Number: 09-059 Start Date*: 2009-07-16
    Sponsor Name:Leids Universitair Medisch Centrum
    Full Title: Sodium Bicarbonate for the prevention of Contrast Induced Nephropathy in patients undergoing CTPA
    Medical condition: The prevention of Contrast Induced Nephropathy is under investigation. Contrast induced nephropathy (CIN) can occur after injecting radiographic iso osmolair contrast media. Patients with a renal i...
    Disease: Version SOC Term Classification Code Term Level
    12.0 10037790 Radiocontrast nephropathy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-000755-17 Sponsor Protocol Number: CompHDL2011 Start Date*: 2011-12-07
    Sponsor Name:Xavier Pintó Sala
    Full Title: Effect of nicotinic adic on the composition of high density lipoprotein (HDL) and endothelial function in patients with premature coronary heart disease and elevated HDL-cholesterol.
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    14.0 10007541 - Cardiac disorders 10008936 Chronic ischaemic heart disease, unspecified LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2010-022041-19 Sponsor Protocol Number: ST198-DNCC-10-001 Start Date*: 2011-01-31
    Sponsor Name:RostaQuo S.p.A.
    Full Title: Effects of L-carnitine administration in patients with elevated Lp(a)levels.
    Medical condition: Dislipidemic patients with Lp(a)>35 mg/dl; LDL-C<190 mg/dl, TG<500 mg/dl
    Disease: Version SOC Term Classification Code Term Level
    9.1 10062060 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-011763-37 Sponsor Protocol Number: ADAVEGF-01 Start Date*: 2009-07-22
    Sponsor Name:ISTITUTO CLINICO HUMANITAS
    Full Title: THE ANTI-ANGIOGENIC EFFECTS OF ADALIMUMAB IN CROHN`S DISEASE
    Medical condition: Crohn`s Disease
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038283 Regional enteritis of small intestine with large intestine LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-001341-34 Sponsor Protocol Number: TCD6595 Start Date*: 2006-07-16
    Sponsor Name:Sanofi-aventis recherche & developpement
    Full Title: Open label, uncontrolled study of XRP9881 in combination with trastuzumab (Herceptin®) in patients with HER2 positive metastatic breast cancer (MBC)
    Medical condition: HER2 positive Metastatic Breast Cancer patients
    Disease: Version SOC Term Classification Code Term Level
    11.1 10033604 LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: BE (Completed) SE (Completed)
    Trial results: View results
    EudraCT Number: 2006-005467-26 Sponsor Protocol Number: 104RA203 Start Date*: 2007-04-12
    Sponsor Name:Biogen Idec Ltd
    Full Title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BG9924 When Given in Combination With Methotr...
    Medical condition: Rheumatoid Arthritis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039073 Rheumatoid arthritis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) BE (Completed)
    Trial results: View results
    EudraCT Number: 2008-004891-28 Sponsor Protocol Number: HM08 / 8451 Start Date*: 2009-09-03
    Sponsor Name:Leeds Teaching Hospitals Trust
    Full Title: Pilot safety/tolerability study of Lenalidomide administered as monotherapy and in combination with standard chemotherapy for Acute Myeloid Leukaemia/high-risk myelodysplastic syndrome with structu...
    Medical condition: Acute myeloid leukaemia / high-risk Myelodysplastic Syndrome with structural abnormalities of chromosome 5
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001941 AML LLT
    9.1 10028533 Myelodysplastic syndrome LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    «« First « Previous 508  509  510  511  512  513  514  515  516  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Sep 17 05:05:43 CEST 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA